Helomics
About:
Helomics provides comprehensive tumor profiling utilizing proprietary tissue-based live cell and fixed cell products and services.
Website: http://www.helomics.com/
Twitter/X: Helomics_
Top Investors: Bain Capital, HealthCare Royalty Partners, Skyline Medical Inc., Longitude Capital, Stephens
Description:
Helomics® is a comprehensive personalized healthcare company, bringing the next generation of diagnostics to the oncology field. Helomics is dedicated to improving patient outcomes by providing a personalized comprehensive tumor profile utilizing a proprietary set of laboratory platforms that leverage both tissue-based live and fixed cellular based analysis allowing physicians to characterize malignant tumors on a personalized basis. Helomics’ novel molecular and cellular markers and bioinformatics services support treatment decisions by providing vital information based on the specific biological processes of each individual’s cancer.
$211M
$1M to $10M
Pittsburgh, Pennsylvania, United States
1995-01-01
info(AT)precisiontherapeutics.com
Paul L. Kornblith
51-100
2017-12-19
Private
© 2025 bioDAO.ai